Opthea Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.08 |
Market Cap |
AUD183.32 M |
Shares Outstanding |
249.41 M |
Public Float |
208.51 M |
Address |
650 Chapel Street South Yarra Victoria (VIC) 3141 Australia |
Employees | - |
Website | http://www.opthea.com |
Updated | 07/08/2019 |
Opthea Ltd. is engaged in developing biological therapeutics for cancer and other serious diseases. It is a biologics drug developer building on its significant intellectual property portfolio around Vascular Endothelial Growth Factor C and D angiogenic molecules and R3. The company focuses on vascular endothelial growth factors to develop truly novel therapies to extend and improve the lives of cancer sufferers. |